Acadian Asset Management
GNMX

Acadian Asset Management’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Acadian Asset Management’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-93,305
Closed -$15K – 2089
2019
Q2 		$15K Sell
93,305
-174,600
-65% -$35.3K ﹤0.01% 1620
2019
Q1 		$53K Buy
267,905
+248,476
+1,279% +$55.1K ﹤0.01% 1658
2018
Q4 		$14K Hold
19,429
– – ﹤0.01% 1588
2018
Q3 		$24K Hold
19,429
– – ﹤0.01% 1493
2018
Q2 		$22K Buy
+19,429
New +$29.5K ﹤0.01% 1521
2015
Q3 		– Sell
-711
Closed -$4K – 1503
2015
Q2 		$4K Buy
+711
New +$5.51K ﹤0.01% 1295

Other funds holding GNMX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return